Neuron23
Biotechnology Research • 
South San Francisco, California, United States • 21-50 Employees
Company overview
| Headquarters | 343 Oyster Point Blvd, Suite 120, South San Francisco, California 94080, US |
| Website | |
| NAICS | 541714 |
| Keywords | IBD, Biotech, Data Science, Precision Medicine, Neurodegenerative Diseases, Inflammatory Diseases, Crohn'S Disease, Parkinson'S Disease, Psoriasis, Autoimmune Diseases, Ulcerative Colitis, Ankylosing Spondylitis, Human Genetics, Neurological Diseases, Immunological Diseases, Neuroinflammatory Diseases |
| Founded | 2018 |
| Employees | 21-50 |
| Socials |
Key Contacts at Neuron23
Eduardo Rojas
Senior Director Program Management
Ray Zhang
Director, Toxicology
Madeline Boyer
Associate Director
Fatta B. Nahab
Executive Director, Clinical And Digital Development
Tyler Molitor
Senior Director - Translational Biology
Scott Savage
Executive Director, Cmc
Chetan Gandhy
Executive Director
Carol Wong
Senior Director
Mei-Yao Lin
Associate Director
Neuron23 Email Formats
Neuron23 uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@neuron23.com), used 79.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@neuron23.com | 79.3% |
{first name}.{last name} | john.doe@neuron23.com | 17.2% |
{first initial} | j@neuron23.com | 3.4% |
About Neuron23
Neuron23™ Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The Company’s focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.
Neuron23 revenue & valuation
| Annual revenue | $4,500,000 |
| Revenue per employee | $125,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $14,400,000 |
| Total funding | $196,500,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Neuron23 has 9 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore Neuron23's funding history, including investment rounds, total capital raised, and key backers.
Neuron23 Tech Stack
Discover the technologies and tools that power Neuron23's digital infrastructure, from frameworks to analytics platforms.
Security
Maps
Recruitment & staffing
CDN
Font scripts
JavaScript libraries
Webmail
Miscellaneous
Programming languages
Blogs
Analytics
France
Spain
United Kingdom
Frequently asked questions
4.8
40,000 users
